DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Munster P, Krischer J, Tamura R. et al.
A randomized community-based trial of an angiotensin converting enzyme inhibitor, lisinopril or a beta blocker, carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving adjuvant trastuzumab.
San Antonio Breast Cancer Symposium 2018 Abstr. GS5-01
We do not assume any responsibility for the contents of the web pages of other providers.